|
1
|
Wall ME, Wani MC, Cook CE, Palmer KH,
McPhail AT and Sim GA: Plant antitumor agents I. The isolation and
structure of camptothecin, a novel alkaloidal leukemia and tumor
inhibitor from Camptotheca acuminata. J Am Chem Soc. 88:3888–3890.
1966. View Article : Google Scholar
|
|
2
|
Liu YQ, Liu ZL, Tian X and Yang L:
Anti-HSV activity of camptothecin analogues. Nat Prod Res.
24:509–514. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bodley AL, Cumming JN and Shapiro TA:
Effect of camptothecin, a topoisomerase I inhibitor on Plasmodium
falciparum. Biochem Pharmacol. 55:709–711. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jensen NF, Agama K, Roy A, Smith DH,
Pfster TD, Romer MU, Zhang HL, Doroshow JH, Knudsen BR, Stenvang J,
et al: Characterization of DNA topoisomerase I in three SN-38
resistant human colon cancer cell lines reveals a new pair of
resistance-associated mutations. J Exp Clin Cancer Res. 35:562016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsiang YH, Hertzberg R, Hecht S and Liu
LF: Camptothecin induces protein-linked DNA breaks via mammalian
DNA topoisomerase I. J Biol Chem. 260:14873–14878. 1985.PubMed/NCBI
|
|
6
|
Liu YQ, Li WQ, Morris-Natschke SL, Qian K,
Yang L, Zhu GX, Wu XB, Chen AL, Zhang SY, Nan X and Lee KH:
Perspectives on biologically active camptothecin derivatives. Med
Res Rev. 35:753–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kawato Y, Aonuma M, Hirota Y, Kuga H and
Sato K: Intracellular roles of SN-38, a metabolite of the
camptothecin derivative CPT-11, in the antitumor effect of CPT-11.
Cancer Res. 51:4187–4191. 1991.PubMed/NCBI
|
|
8
|
Kingsbury WD, Boehm JC, Jakas DR, Holden
KG, Hecht SM, Gallagher G, Caranfa MJ, McCabe FL, Faucette LF,
Johnson RK, et al: Synthesis of water-soluble (aminoalkyl.
camptothecin analogues: inhibition of topoisomerase I and antitumor
activity. J Med Chem. 34:98–107. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
LEE JH, Lee JM, Kim JK, Ahn SK, Lee SJ,
Kim MY, Jew SS, Park JG and Hong CI: Antitumor activity of
7-(2-(N-Isopropylamino)ethyl)-(20S)-camptothecin, CKD602, as a
potent DNA topoisomerase I inhibitor. Arch Pharm Res. 21:581–590.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pommier Y: Topoisomerase I inhibitors:
Camptothecins and beyond. Nat Rev Cancer. 6:789–802. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Süsskind D, Hagemann U, Schrader M,
Januschowski K, Schnichels S and Aisenbrey S: Toxic effects of
melphalan, topotecan and carboplatin on retinal pigment epithelial
cells. Acta Ophthalmol. 94:471–478. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma JY, Tong SM, Wang PW, Liao WL, Liu HB
and Zhang LQ: Insecticidal activity of camptothecin against
Nilaparvata lugens, Brevicoryne brassicae, and Chilo suppressalis.
J Econ Entomol. 10:492–496. 2010. View
Article : Google Scholar
|
|
13
|
Liu YQ, Yang L, Zhao YL and Li HY:
Synthesis of novel derivatives of camptothecin as potential
insecticides. Pest Biochem Physio. 198:219–223. 2010. View Article : Google Scholar
|
|
14
|
Liu YQ, Dai W and Tian J: Synthesis and
insecticidal activities of novel spin-labeled derivatives of
camptothecin. Heteroatom Chem. 22:687–691. 2011. View Article : Google Scholar
|
|
15
|
Tang D, Cui Y and Chen G:
Nanoparticle-based immunoassays in the biomedical field. Analyst.
138:981–90. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Samori C, Guerrini A, Varchi G, Fontana G,
Bombardelli E and Tinelli S: Semisynthesis, biological activity,
and molecular modeling studies of C-ring-modified camptothecins. J
Med Chem. 52:1029–1039. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu H, Lin H, Jiang Y, Zhou X, Wu B and
Chen J: Synthesis and antitumor activity of 20-O-linked
succinate-based camptothecin ester derivatives. Lett Drug Design
Discovery. 3:83–86. 2006. View Article : Google Scholar
|
|
18
|
Seigo S, Ken-ichiro N, Tomio F, Teruo Y
and Tadashi M: Chemical modification of an antitumor alkaloid
camptothecin: synthesis and antitumor activity of 7-C-substitude
camptothecins. Chem Pharm Bull. 39:2574–2580. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peeters JM, Hazendonk TG, Beuvery EC and
Tesser GI: Comparison of four bifunctional reagents for coupling
peptides to proteins and the effect of the three moieties on the
immunogenicity of the conjugates. J Immunol Methods. 120:133–143.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hua Lu, Haixia Lin, Yi Jiang, Xinguang
Zhou, Beili Wu and Jianmin Chen: Synthesis and Antitumor Activity
of 20-O-Linked Succinate-Based Camptothecin Ester Derivatives.
Letters in Drug Design & Discovery. 3:83–86. 2006. View Article : Google Scholar
|
|
21
|
Gendloff EH, Casale WL, Ram BP, Tai JH,
Pestka JJ and Hart LP: Hapten-protein conjugates prepared by the
mixed anhydride method. Cross-reactive antibodies in heterologous
antisera. J Immunol Methods. 92:15–20. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jang MS, Lee SJ, Xue X, Kwon HM, Ra CS,
Lee YT and Chung TW: Production and characterization of monoclonal
antibodies to a generic hapten for-class-specific determination of
organophosphorus pesticides. Bulletin of the Korean Chemical Soc.
23:1116–1119. 2002. View Article : Google Scholar
|
|
23
|
Vladu B, Woynaowski JM, Manikumar G, Wani
MC, Wall ME, Von Hoff DD and Wadkins RM: 7- and 10-Substituted
Camptothecins: Dependence of Topoisomerase I-DNA Cleavable Complex
Formation and Stability on the 7- and 10-Substituents. Mol
Pharmacol. 57:243–51. 2000.PubMed/NCBI
|
|
24
|
Trier NH, Hansen PR and Houen G:
Production and characterization of peptide antibodies. Methods.
56:136–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang Y, Liu XJ, Liu Y, Yu XY and Fan MT:
Synthesis of three haptens for the class-specific immunoassay of
O,O-dimethyl organophosphorus pesticides and effect of hapten
heterology on immunoassay sensitivity. Anal Chim Acta. 615:174–83.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Burkin MA and Galvidis IA: Hapten
modification approach for switching immunoassay specificity from
selective to generic. J Immunol Methods. 388:60–67. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Esteve-Turrillas FA, Agulló C, Mercader
JV, Abad-Somovilla A and Abad-Fuentes A: Rationally designed
haptens for highly sensitive monoclonal antibody-based
immunoanalysis of fenhexamid. Analyst. 143:4057–4066. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang MJ, Liu YQ, Chang LC, Wang CY, Zhao
YL, Zhao XB, Qian KD, Nan X, Yang L, Yang XM, et al: Design,
synthesis, mechanisms of action, and toxicity of novel
20(S)-sulfonylamidine derivatives of camptothecin as potent
antitumor agents. J Med Chem. 57:6008–6018. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sriram D, Yogeeswari P, Thirumurugan R and
Bal TR: Camptothecin and its analogues: A review on their
chemotherapeutic potential. Mat Prod Res. 19:393–412. 2005.
|
|
30
|
Sawada H and Matsuoka YG: Effect of a
nitrofuran derivative (AF2) on the immune response of mice. Gan.
67:693–701. 1976.PubMed/NCBI
|
|
31
|
Cao Z, Harris N, Kozielski A, Vardeman D,
Stehlin JS and Giovanella B: Alkyl esters of camptothecin and
9-nitrocamptothecin: Synthesis, in vitro pharmacokinetics,
toxicity, and antitumor activity. J Med Chem. 41:31–37. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Safavy A, Georg G, Vander Velde D, Raisch
KP, Safavy K, Carpenter M, Wang W, Bonner JA, Khazaeli MB and
Buchsbaum DJ: Site-specifically traced drug release and
biodistribution of a paclitaxel-antibody conjugate toward
improvement of the linker structure. Bioconjug Chem. 15:1264–1274.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang Q, Wang L and Lu W: Evolution in
medicinal chemistry of E-ring-modified Camptothecin analogs as
anticancer agents. Eur J Med Chem. 63:746–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Giesecke C, Meyer T, Durek P, Maul J,
Preiß J, Jacobs JFM, Thiel A, Radbruch A, Ullrich R and Dörner T:
Simultaneous presence of non- and highly mutated keyhole limpet
hemocyanin (KLH)-Specific Plasmablasts Early after Primary KLH
immunization suggests cross-reactive memory B Cell Activation. J
Immunol. 200:3981–3992. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cruz LJ, Cabrales A, Iglesias E, Aguilar
JC, González LJ and Reyes O: Enhanced immunogenicity and
cross-reactivity of HIV-1 V3-peptide and multiple antigen peptides
conjugated to distinct carrier proteins. Int Immunopharmacol.
9:1452–1459. 2009. View Article : Google Scholar : PubMed/NCBI
|
